Joint and cartilage repair pathways

Joint and cartilage repair pathways encompass the integrated biological processes that maintain the structural integrity of articular joints and facilitate the regeneration of damaged cartilage [11, 12]. These pathways involve a variety of signaling molecules, including the Transforming Growth Factor-beta (TGF-β) superfamily, Bone Morphogenetic Proteins (BMPs), Fibroblast Growth Factors (FGFs), and the Wnt/β-catenin signaling system [13, 18, 19]. These signals coordinate the activity of chondrocytes, the primary cells in cartilage, to regulate the synthesis and degradation of the extracellular matrix (ECM), which is rich in type II collagen and proteoglycans [1, 2, 8]. In diseases like osteoarthritis, the balance between anabolic and catabolic processes is disrupted, leading to progressive cartilage loss and joint dysfunction [4, 9]. Therapeutic interventions targeting these pathways, such as FGF18 analogs (e.g., sprifermin) or Wnt pathway modulators (e.g., lorecivivint), aim to stimulate chondrogenesis and ECM production to restore joint function [3, 5, 10]. However, the complexity and crosstalk between these pathways present significant challenges, including the risk of unwanted bone formation or inflammation within the joint space [13, 16]. Emerging research also explores the role of gerozymes and specific kinase inhibitors to reverse age-related cartilage loss [15]. Successful modulation of these pathways requires localized delivery to minimize systemic side effects and ensure targeted tissue regeneration [17].

Other names

Cartilage regeneration pathwaysChondrogenesis pathwaysArticular cartilage repair mechanismsJoint tissue repair pathways

Modulation of signaling cascades (FGF, Wnt, TGF-beta, BMP) to stimulate chondrocyte proliferation, enhance extracellular matrix (ECM) synthesis, and inhibit catabolic enzymes.